302 related articles for article (PubMed ID: 27061718)
1. Effect of permeability enhancers on paracellular permeability of acyclovir.
Ates M; Kaynak MS; Sahin S
J Pharm Pharmacol; 2016 Jun; 68(6):781-90. PubMed ID: 27061718
[TBL] [Abstract][Full Text] [Related]
2. Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport.
Dahlgren D; Roos C; Lundqvist A; Tannergren C; Sjöblom M; Sjögren E; Lennernäs H
Int J Pharm; 2018 Oct; 549(1-2):239-248. PubMed ID: 30055302
[TBL] [Abstract][Full Text] [Related]
3. In vitro assessment of acyclovir permeation across cell monolayers in the presence of absorption enhancers.
Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
Drug Dev Ind Pharm; 2008 Mar; 34(3):279-88. PubMed ID: 18363143
[TBL] [Abstract][Full Text] [Related]
4. Modulation of ganciclovir intestinal absorption in presence of absorption enhancers.
Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
J Pharm Sci; 2007 Oct; 96(10):2710-22. PubMed ID: 17680662
[TBL] [Abstract][Full Text] [Related]
5. Improvement of intestinal absorption of forsythoside A in weeping forsythia extract by various absorption enhancers based on tight junctions.
Zhou W; Qin KM; Shan JJ; Ju WZ; Liu SJ; Cai BC; Di LQ
Phytomedicine; 2012 Dec; 20(1):47-58. PubMed ID: 23089157
[TBL] [Abstract][Full Text] [Related]
6. The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs.
Dahlgren D; Roos C; Johansson P; Tannergren C; Lundqvist A; Langguth P; Sjöblom M; Sjögren E; Lennernäs H
Int J Pharm; 2018 Aug; 547(1-2):158-168. PubMed ID: 29758344
[TBL] [Abstract][Full Text] [Related]
7. Capric Acid Absorption in the Presence of Hydroxypropyl-β-Cyclodextrin in the Rat Ileum using the In Situ Single-Pass Perfusion Technique.
Hymas RV; Ho NF; Higuchi WI
J Pharm Sci; 2015 Sep; 104(9):2832-44. PubMed ID: 25393711
[TBL] [Abstract][Full Text] [Related]
8. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
[TBL] [Abstract][Full Text] [Related]
9. Effects of pharmaceutical excipients on membrane permeability in rat small intestine.
Takizawa Y; Kishimoto H; Nakagawa M; Sakamoto N; Tobe Y; Furuya T; Tomita M; Hayashi M
Int J Pharm; 2013 Sep; 453(2):363-70. PubMed ID: 23742974
[TBL] [Abstract][Full Text] [Related]
10. Preclinical Effect of Absorption Modifying Excipients on Rat Intestinal Transport of Model Compounds and the Mucosal Barrier Marker
Dahlgren D; Roos C; Lundqvist A; Tannergren C; Langguth P; Sjöblom M; Sjögren E; Lennernäs H
Mol Pharm; 2017 Dec; 14(12):4243-4251. PubMed ID: 28737406
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of some pharmaceutically acceptable excipients as permeation enhancers for amoxicillin.
Legen I; Kracun M; Salobir M; Kerc J
Int J Pharm; 2006 Feb; 308(1-2):84-9. PubMed ID: 16330171
[TBL] [Abstract][Full Text] [Related]
12. Effects of absorption-modifying excipients on jejunal drug absorption in simulated fasted and fed luminal conditions.
Roos C; Dahlgren D; Sjögren E; Sjöblom M; Hedeland M; Lennernäs H
Eur J Pharm Biopharm; 2019 Sep; 142():387-395. PubMed ID: 31306752
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers.
Parr A; Hidalgo IJ; Bode C; Brown W; Yazdanian M; Gonzalez MA; Sagawa K; Miller K; Jiang W; Stippler ES
Pharm Res; 2016 Jan; 33(1):167-76. PubMed ID: 26286187
[TBL] [Abstract][Full Text] [Related]
14. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):874-83. PubMed ID: 16243320
[TBL] [Abstract][Full Text] [Related]
15. The effect of chitosan on the bioaccessibility and intestinal permeability of acyclovir.
Kubbinga M; Augustijns P; García MA; Heinen C; Wortelboer HM; Verwei M; Langguth P
Eur J Pharm Biopharm; 2019 Mar; 136():147-155. PubMed ID: 30682491
[TBL] [Abstract][Full Text] [Related]
16. Effects of sodium deoxycholate and sodium caprate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats.
Lo YL; Huang JD
Biochem Pharmacol; 2000 Mar; 59(6):665-72. PubMed ID: 10677583
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetics and Intestinal Absorption of Curcumin Chitosan Hydrochloride Coated Liposome in Rats].
Wan SL; Zhong M; Yang M; Hu XY; Zhang JQ
Zhong Yao Cai; 2015 Jan; 38(1):132-5. PubMed ID: 26214883
[TBL] [Abstract][Full Text] [Related]
18. Effect of chitosan glutamate, carbomer 974P, and EDTA on the in vitro Caco-2 permeability and oral pharmacokinetic profile of acyclovir in rats.
Merzlikine A; Rotter C; Rago B; Poe J; Christoffersen C; Thomas VH; Troutman M; El-Kattan A
Drug Dev Ind Pharm; 2009 Sep; 35(9):1082-91. PubMed ID: 19294548
[TBL] [Abstract][Full Text] [Related]
19. Permeabilities of rebamipide via rat intestinal membranes and its colon specific delivery using chitosan capsule as a carrier.
Huang BB; Li GF; Luo JH; Duan L; Nobuaki K; Akira Y
World J Gastroenterol; 2008 Aug; 14(31):4928-37. PubMed ID: 18756602
[TBL] [Abstract][Full Text] [Related]
20. Intestinal permeability of forskolin by in situ single pass perfusion in rats.
Liu ZJ; Jiang DB; Tian LL; Yin JJ; Huang JM; Weng WY
Planta Med; 2012 May; 78(7):698-702. PubMed ID: 22411728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
